MultiPark: Multidisciplinary research on neurodegenerative diseases
1 – 10 of 4386
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Galectin 3 : A new player in the pathogenesis of Parkinson's disease
- Contribution to journal › Article
- 2025
-
Mark
Plasma neurofilament light chain is increased in Niemann-Pick Type C but glial fibrillary acidic protein remains normal
- Contribution to journal › Article
-
Mark
Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-α-Syn + PFFs-induced rat model for Parkinson's disease
- Contribution to journal › Article
-
Mark
Autologous cells, no longer lost in translation
- Contribution to journal › Debate/Note/Editorial
-
Mark
Optimizing peptide nucleic acid-based pretargeting for enhanced targeted radionuclide therapy
- Contribution to journal › Article
-
Mark
Neurophysiological Treatment Effects of Mesdopetam, Pimavanserin and Amantadine in a Rodent Model of Levodopa-Induced Dyskinesia
- Contribution to journal › Article
-
Mark
Deficiency of Peptidylglycine-alpha-amidating Monooxygenase, a Cause of Sarcopenic Diabetes Mellitus
- Contribution to journal › Article
-
Mark
A Federated Data Analysis Approach for the Evaluation of Surrogate Endpoints
- Contribution to journal › Article
-
Mark
A systematic screening assay identifies efficient small guide RNAs for CRISPR activation
- Contribution to journal › Article
-
Mark
Stakeholder Perspectives on Built Environmental Factors to Support Stroke Rehabilitation and Return to Everyday Life
- Contribution to journal › Article
